CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents ($49,227 and $75,458 restricted at December 31, 2020 and March 31, 2021, respectively)	$ 456,309	$ 1,144,450
Accounts receivable, net	793,504	743,502
Short-term investments ($88,867 and $74,312 restricted at December 31, 2020 and March 31, 2021, respectively)	625,600	140,847
Pharmaceutical inventory	46,389	43,334
Other current assets ($43,547 and $51,511 restricted at December 31, 2020 and March 31, 2021, respectively)	101,462	84,264
Total Current Assets	2,023,264	2,156,397
Property and equipment, net	142,084	136,739
Long-term investments ($1,026 and $2,615 restricted at December 31, 2020 and March 31, 2021, respectively)	4,830	2,612
Deferred income taxes	921	1,842
Other long-term assets	119,947	108,797
Goodwill	873,830	873,779
Other intangible assets, net	71,631	79,689
Total Assets	3,236,507	3,359,855
Current Liabilities:
Accounts payable	149,760	137,380
Accrued liabilities	266,217	354,906
Medical claims payable	116,580	111,851
Other medical liabilities	123,109	126,921
Current debt, finance lease and deferred financing obligations	6,543	6,521
Total Current Liabilities	662,209	737,579
Long-term debt, finance lease and deferred financing obligations	526,682	631,855
Deferred income taxes	13,602	7,102
Tax contingencies	11,867	11,002
Deferred credits and other long-term liabilities	79,276	69,283
Total Liabilities	1,293,636	1,456,821
Redeemable non-controlling interest	33,303	33,062
STOCKHOLDERS' EQUITY
Preferred stock, par value $.01 per share Authorized-10,000 shares at December 31, 2020 and March 31, 2021-Issued and outstanding-none
Common stock, par value $.01 per share: Authorized-100,000 shares at December 31, 2020 and March 31, 2021-Issued and outstanding-55,549 and 25,887 shares at December 31, 2020, respectively, and 55,789 and 26,127 shares at March 31, 2021, respectively	558	555
Other Stockholders' Equity:
Additional paid-in capital	1,488,975	1,477,219
Retained earnings	1,884,957	1,857,130
Accumulated other comprehensive income (loss)	(195)	(205)
Treasury stock, at cost, 29,662 and 29,662 shares at December 31, 2020 and March 31, 2021, respectively	(1,464,727)	(1,464,727)
Total Stockholders' Equity	1,909,568	1,869,972
Total Liabilities and Stockholders' Equity	$ 3,236,507	$ 3,359,855